000 | 01675 a2200493 4500 | ||
---|---|---|---|
005 | 20250515182330.0 | ||
264 | 0 | _c20091020 | |
008 | 200910s 0 0 rus d | ||
022 | _a0022-9040 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBatyraliev, T A | |
245 | 0 | 0 |
_a[The use of tirofiban in invasive treatment of patients with non-ST-elevation acute coronary syndrome]. _h[electronic resource] |
260 |
_bKardiologiia _c2009 |
||
300 |
_a13-8 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Randomized Controlled Trial | ||
650 | 0 | 4 |
_aAcute Coronary Syndrome _xphysiopathology |
650 | 0 | 4 |
_aAngioplasty, Balloon, Coronary _xmethods |
650 | 0 | 4 |
_aCoronary Artery Bypass _xmethods |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aElectrocardiography |
650 | 0 | 4 | _aExercise Test |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInjections, Intravenous |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xadministration & dosage |
650 | 0 | 4 |
_aPlatelet Glycoprotein GPIIb-IIIa Complex _xantagonists & inhibitors |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 |
_aStroke Volume _xphysiology |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTirofiban |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aTyrosine _xadministration & dosage |
650 | 0 | 4 |
_aVentricular Function, Left _xphysiology |
700 | 1 | _aFettser, D V | |
700 | 1 | _aVural, A | |
700 | 1 | _aPershukov, I V | |
700 | 1 | _aPreobrazhenskiĭ, D V | |
700 | 1 | _aAvsar, O | |
700 | 1 | _aSidorenko, B A | |
773 | 0 |
_tKardiologiia _gvol. 49 _gno. 7-8 _gp. 13-8 |
|
999 |
_c19063010 _d19063010 |